A computational approach to compare microvessel distributions in tumors following antiangiogenic treatments

Laboratory Investigation

Volumn 89, Issue 9, 2009, Pages 1063-1070

  Righi, Marco ^a,b   Giacomini, Arianna ^b,c   Lavazza, Cristiana ^b,c   Sia, Daniela ^b,c   Carlo Stella, Carmelo ^b,c   Gianni, Alessandro M ^b,c  

^a CNR   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Angiogenesis; Image analysis; Mathematical morphology; Microvessel distribution; Vascular targeted therapies

Indexed keywords

SORAFENIB;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IN VIVO STUDY; MATHEMATICAL COMPUTING; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCID MOUSE; STAINING; TARGET ORGAN; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; VALIDATION PROCESS; VASCULAR TISSUE;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; BENZENESULFONATES; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MICE; MICE, SCID; MICROVESSELS; NEOPLASM TRANSPLANTATION; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PYRIDINES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 69349094901     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2009.76     Document Type: Article

References (36)

1. Arap W, Pasqualini R, Ruoslahti E. Cancer treatment by target drug delivery to tumor vasculature in a mouse model. Science 1998;279:377-380. (Pubitemid 28063372)
2. Denekamp J. The tumor microcirculation as a target in cancer therapy: a clearer perspective. Eur J Clin Invest 1999;29:733-736. (Pubitemid 29425513)
3. Kerbel RS. Tumor angiogenesis. N Engl J Med 2008;358:2039-2049.
4. Leighl NB, Paz-Arez L, Douillard JL, et al. Randomized phase III study of matrix metalloproteinase inhibitor BMS-275291 in combination with paclitaxel and carboplatin in advanced nonsmall-cell lung cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR. 18. J Clin Oncol 2005;23:2831-2839.
5. Siemann DW, Chaplin DJ, Horsman MR. Vascular-targeting therapies for treatment of malignant disease. Cancer 2004;100:2491-2499. (Pubitemid 38715753)
6. Degner FL, Sutherland RM. Theoretical evaluation of expected changes in oxygenation of tumors associated with different haemoglobin levels. Int J Radiat Oncol Biol Phys 1986;12:1291-1294.
7. Mulrane L, Rexhepaj E, Smart V, et al. Creation of a digital slide and tissue microarray resource from a multi-institutional predictive toxicology study in the rat: an initial report from the PredTox group. Exp Toxicol Pathol 2008;60:235-245.
8. Dagnon K, Heudes D, Bernaudin JF, et al. Computerized morphometric analysis of microvasculature in non-small cell lung carcinoma. Microvasc Res 2008;75:112-118. (Pubitemid 350266731)
9. Belien JA, Somi S, de Jong JS, et al. Fully automated microvessel counting and hot spot selection by image processing of whole tumor sections in invasive breast cancer. J Clin Pathol 1999;52:184-192. (Pubitemid 29125410)
10. Axelsson K, Ljung BM, Moore II DH, et al. Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J Natl Cancer Inst 1995;87:997-1008.
11. Barbareschi M, Weidner N, Gasparini G, et al. Microvessel density quantification in breast carcinomas: assessment by light microscopy vs. a computer-aided image analysis system. Appl Immunohistochem 1995;3:75-84.
12. Mandelbrot B. The Fractal Geometry of Nature. Freeman: New York, 1983.
13. Cross SS. Fractals in pathology. J Pathol 1997;182:1-8.
14. Baish JW, Jain RK. Fractals and cancer. Cancer Res 2000;60:3683-3688.
15. Baish JW, Gazit Y, Berk DA, et al. Role of tumor vascular architecture in nutrient and drug delivery: an invasion percolation-based network model. Microvasc Res 1996;51:327-346. (Pubitemid 26162001)
16. Sandau K, Kurz H. Measuring fractal dimension and complexity - an alternative approach with an application. J Microsc 1997;186:164-176. (Pubitemid 27244734)
17. Chung HW, Chung HJ. Correspondence re: J. W. Baish and R. K. Jain, Fractals and cancer. Cancer Res 2001;61:8347-8350.
18. Masters BR. Fractal analysis of normal human retinal blood vessels. Fractals 1994;2:103-110.
19. Serra J. Biomedical image analysis by mathematical morphology. Pathol Biol (Paris) 1979;27:205-207. (Pubitemid 9182237)
20. Serra J. Image Analysis and Mathematical Morphology. Academic Press: New York, 1983.
21. Scott W, Carter C, Lynch M, et al. Discovery and development of sorafenib: a multikinase inhibitor for treating cancer. Nat Rev Drug Discov 2006;5:835-844. (Pubitemid 44480537)
22. Rybak JN, Ettorre A, Kaissling B, et al. In vivo protein biotinylation for identification of organ-specific antigens accessible from the vasculature. Nat Methods 2005;2:291-298.
23. Chayes F. The Holmes effect and the lower limit of modal analysis. Mineral Mag 1956;31:276-281.
24. Rasband WS, Image J, US National Institutes of Health, Bethesda, MD, USA, http://rsb.info.nih.gov/ij/, 1997-2008.
25. Mann HB, Whitney DR. On a test of whether one of two random variables is stochastically larger than the other. Ann Math Statist 1947;18:50-60.
26. Grizzi F, Russo C, Colombo P, et al. Quantitative evaluation and modeling of two-dimensional neovascular network complexity: the surface fractal dimension. BMC Cancer 2005;5:14-22. (Pubitemid 41461113)
27. Bouligand C. Sur la notion d'ordre de mesure d'un ensemble plan. Bull Sci Math 1929;2:185-192.
28. Zhou YJ, Wang SQ, Zhang J, et al. A novel method to isolate and map endothelial membrane proteins from pulmonary vasculature. Am J Physiol 2005;288:C950-C956. (Pubitemid 40395074)
29. McDonald DM, Choyke PL. Imaging of angiogenesis: from microscope to clinic. Nat Med 2003;9:713-725.
30. Smith AR. Color gamut transform Pairs. Comput Graph (ACM) 1978;12:12-19. doi:10.1145/965139.807361.
31. MacGillivray TJ, Patton N. A reliability study of fractal analysis of the skeletonised vascular network using the 'box-counting' technique. Conf Proc IEEE Eng Med Biol Soc 2006;1:4445-4448.
32. Siemann DW, Bibby MC, Dark GG, et al. Differentiation and definition of vascular-targeted therapies. Clin Cancer Res 2005;11: 416-420.
33. Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis. J Am Med Assoc 1932;99:1323-1329.
34. Podolsky DK. Inflammatory bowel disease (1). N Engl J Med 1991;325:928-937.
35. Stefanelli T, Malesci A, Repici A, et al. New insights into inflammatory bowel disease pathophysiology: paving the way for novel therapeutic targets. Curr Drug Targets 2008;9:413-418. (Pubitemid 352025216)
36. Deban L, Correale C, Vetrano S, et al. Multiple pathogenic role of microvasculature in inflammatory bowel disease: a jack of all trades. Am J Pathol 2008;172:1457-1466. (Pubitemid 351793339)